-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Reimagining Cancer Care at Syndax: Clinical Development of Targeted Therapies

Sponsor: Syndax Pharmaceuticals
Program: Company Showcases
Saturday, December 9, 2023: 3:30 PM-3:45 PM
Room 5A (San Diego Convention Center)
Neil Gallagher, MD, PhD, Syndax Pharmaceuticals and Kate Madigan, Syndax Pharmaceuticals, Inc.
Madigan: Syndax Pharmaceuticals: Current Employment, Current holder of stock options in a privately-held company.
For In-Person Participants Only
See more of: Company Showcases